A proposed partial settlement of 20 million CAD has been reached in the Canada-wide class actions against Philips Respironics, addressing economic loss claims related to the recall of certain CPAP, Bi ...

We said to buy shares in early July 2024, when the stock had gotten knocked down to $192. The market was concerned a new Eli Lilly pill would reduce patients’ obstructive sleep apnea, or OSA, enough ...

On June 2022 Philips Respironics has issued a recall notification for patients using CPAP and BiPAP machines that they produced.

Philips recalled millions of CPAPs, BiPAPs and ventilators after the FDA received reports that foam insulation inside the machines was a health risk and potential carcinogen.

There are two new settlements for Philips CPAP sleep apnea machines. One is for personal injury claims and the other is for medical monitoring.